| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
3,187,500 | 3,182,700 | 2,877,400 | 2,327,500 | 1,936,300 |
| Cost of Revenue
|
-435,400 | -384,400 | -309,700 | -257,500 | -151,600 |
|
Gross Profit
|
2,752,100 | 2,798,300 | 2,567,700 | 2,070,000 | 1,784,700 |
| Selling, General and Administrative Expenses
|
-793,500 | -731,100 | -638,600 | -477,100 | -482,100 |
|
Research and Development Expenses
|
-703,200 | -550,000 | -481,000 | -408,000 | -322,900 |
|
Operating Income/Expenses
|
-1,496,700 | -1,281,100 | -1,119,600 | -885,100 | -805,000 |
|
Total Operating Profit/Loss
|
1,255,400 | 1,517,200 | 1,448,100 | 1,184,900 | 979,700 |
| Total Net Finance Income/Expense
|
138,300 | 172,500 | 156,200 | 103,400 | 12,800 |
| Irregular Income/Expenses
|
65,700 | -24,700 | -71,100 | 0 | -1,700 |
|
Other Income/Expense, Non-Operating
|
48,400 | 48,900 | 5,800 | -14,000 | -40,200 |
|
Non-Operating Income/Expenses, Total
|
252,400 | 196,700 | 90,900 | 89,400 | -29,100 |
|
Pretax Income
|
1,507,800 | 1,713,900 | 1,539,000 | 1,274,300 | 950,600 |
|
Provision for Income Tax
|
-277,000 | -379,200 | -343,900 | -289,500 | -223,300 |
|
Net Income from Continuing Operations
|
1,230,800 | 1,334,700 | 1,195,100 | 984,800 | 727,300 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
1,230,800 | 1,334,700 | 1,195,100 | 984,800 | 727,300 |
|
Net Income after Non-Controlling/Minority Interests
|
1,230,800 | 1,334,700 | 1,195,100 | 984,800 | 727,300 |
|
Net Income Available to Common Stockholders
|
1,230,800 | 1,334,700 | 1,195,100 | 984,800 | 727,300 |
|
Diluted Net Income Available to Common Stockholders
|
1,230,800 | 1,334,700 | 1,195,100 | 984,800 | 727,300 |
| Basic EPS
|
28.61 | 30.13 | 26.44 | 21.04 | 15.98 |
| Diluted EPS
|
26.50 | 27.86 | 24.64 | 19.81 | 15.00 |
|
Basic Weighted Average Shares Outstanding
|
43,025 | 44,300 | 45,200 | 46,800 | 45,500 |
|
Diluted Weighted Average Shares Outstanding
|
46,400 | 47,900 | 48,500 | 49,700 | 48,500 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
1,369,500 | 1,541,400 | 1,382,800 | 1,170,900 | 937,800 |
|
EBITDA
|
1,465,500 | 1,627,000 | 1,455,300 | 1,224,100 | 989,100 |
|
Normalized EBITDA
|
1,557,100 | 1,799,400 | 1,670,400 | 1,266,800 | 1,107,900 |
|
Normalized Income
|
1,305,572.07 | 1,468,999.60 | 1,362,878 | 1,017,679 | 818,776 |
|
Total Unusual Items
|
91,600 | 172,400 | 215,100 | 42,700 | 118,800 |
|
Total Unusual Items Excluding Goodwill
|
91,600 | 172,400 | 215,100 | 42,700 | 118,800 |
|
Tax Effect of Unusual Items
|
16,827.93 | 38,100.40 | 47,322 | 9,821 | 27,324 |
12/31/2022 - 6/17/1999
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade